logo
Select company
Select metric
Ticker Information

Ticker

APVO

Company Name

APTEVO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

APTEVO THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

APVO - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -23.76M0%$ 0
3/31/2025$ -23.4M0%$ 0
12/31/2024$ -23.78M0%$ 0
9/30/2024$ -23.32M0%$ 0
6/30/2024$ -24.52M0%$ 0
3/31/2024$ -26.52M0%$ 0
12/31/2023$ -16.84M0%$ 0
9/30/2023$ -15.54M0%$ 0
6/30/2023$ -16.75M0%$ 0
3/31/2023$ 19.33M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for APTEVO THERAPEUTICS INC is calculated as follows: EBITDA [ $ -16.27M ] / Revenues [ $ 10.97M ]
(=) EBITDA % [ -148.4% ]

APVO - EBITDA Margin, Last 5 years

-396.18%

Minimum

Mar 31, 2021

286.71%

Maximum

Dec 31, 2022

-143.36%

Average

-218.15%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%